Continuous glucose monitoring is more sensitive than HbA1c and fasting glucose in detecting dysglycaemia in a Spanish population without diabetes
Diabetes Research and Clinical Practice Jun 01, 2018
Rodriguez-Segade S, et al. - Study authors attempted to examine whether continuous glucose monitoring (CGM) reveals patterns of glycaemic behaviour, the detection of which might improve early diagnosis of dysglycaemia. For this analysis, an aggregate one thousand, five hundred twenty-one complete days of valid CGM data were recorded under real-life conditions from a healthy sample of a Spanish community, as were matching FPG and HbA1c data. No participant in this investigation was pregnant, had a history of kidney or liver disease, or was taking drugs known to affect glycaemia. On the basis of the data collected, it was concluded that CGM was a better indicator of possible early dysglycaemia than either FPG or HbA1c.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries